本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Black Diamond Therapeutics, Inc.

2.59
-0.0150-0.58%
盘后2.54-0.0450-1.74%15:08 EDT
成交量:47.22万
成交额:122.46万
市值:1.47亿
市盈率:29.34
高:2.66
开:2.63
低:2.54
收:2.60
数据加载中...
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/11

重要事件披露

Form 8-K - Current report
2024/03/12

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/12

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/12

重要事件披露

Form 8-K - Current report